The latest closing stock price for Innate Pharma S.A as of September 19, 2024 is 2.25.
An investor who bought $1,000 worth of Innate Pharma S.A stock at the IPO in 2019 would have $-634 today, roughly -1 times their original investment - a -18.19% compound annual growth rate over 5 years.
The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
The Innate Pharma S.A 52-week high stock price is 3.15, which is 40% above the current share price.
The Innate Pharma S.A 52-week low stock price is 1.81, which is 19.6% below the current share price.
The average Innate Pharma S.A stock price for the last 52 weeks is 2.46.
An investor who bought $1,000 worth of Innate Pharma S.A stock at the IPO in 2019 would have $-634 today, roughly -1 times their original investment - a -18.19% compound annual growth rate over 5 years.
The all-time high Innate Pharma S.A stock closing price was 8.20 on May 11, 2020.
The Innate Pharma S.A 52-week high stock price is 3.15, which is 40% above the current share price.
The Innate Pharma S.A 52-week low stock price is 1.81, which is 19.6% below the current share price.
The average Innate Pharma S.A stock price for the last 52 weeks is 2.46.